+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ampio Pharmaceuticals Inc - logo

Ampio Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio has received over 180 patents throughout the world, with hundreds more pending. The company's leading product candidates are Ampion and Optina. Amption is a intra-articular injection being studied for the treatment of osteoarthritis of the knee. Optina is an oral agent being studied for the treatment of diabetic macular edema. Ampio is headquartered in Englewood, Colorado.

Knee osteoarthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Knee osteoarthritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020 - Product Thumbnail Image

Calcitonin Gene Related Peptide - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 Pages
  • Global
From
From
From
From
Wet Macular Degeneration - Pipeline Insight, 2024 - Product Thumbnail Image

Wet Macular Degeneration - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 122 Pages
  • Global
From
Diabetic Macular Edema - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 319 Pages
  • Global
From
From
Immunology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 450 Pages
  • Global
From
Loading Indicator